| Name | Title | Contact Details |
|---|
Affiliated Sante Group is a Silver Spring, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Rightway Healthcare combines cutting edge patient navigation and analytics to optimize healthcare expenditure for employers and employees
WCCT Global is a multi-site, full service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive for tomorrow’s therapies to be available today” truly exemplifies the focus and reason for our cutting edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory, program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.
We help healthcare organizations grow intelligently. Our technology enables deeper connections with consumers and physicians through more complete information and the tools to reach them. Payers & Providers can now thrive in the evolving healthcare landscape. Tea Leaves merger with Everyday Health, Inc., created a powerful marketing, communications and growth solution for health systems. Tea Leaves Health’s strategic growth platform, coupled with Everyday Health’s content, audience, data, and expertise in sales and marketing, provides a robust solution for hospital systems to drive their strategic marketing objectives. The combination of Tea Leaves technology and Everyday Health, Inc.’s capabilities creates a powerful tool for hospital systems to reach high-value consumers, positively affect physician relationships and strategically grow health systems through deepening relationships that drive their business.
For more than 130 years, Boehringer Ingelheim has been committed to the research, development, and manufacturing of new medications with high therapeutic value for people and animals. As a family-owned pharmaceutical company, Boehringer Ingelheim is able to take a long-term view and invest heavily in research and development. We are proud of addressing some of the most challenging healthcare issues. Our vision – value through innovation – has always characterized our collaborative work, and is for us simultaneously a fundamental requirement and a driving force. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally through 145 affiliates and a total of some 47,500 employees.